Delivery Order SPE2DB22D3301-SPE2DB26FX4DU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Calquence 100 mg tablets (60-count units) valued at $11,187.56. This firm fixed-price delivery order, which is expected to be completed by August 8, 2025, represents a non-competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the vendor's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $11,187.56 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Calquence 100 mg tablets (60-count units). The contract is firm fixed price with no set-aside designation and is scheduled for completion by September 30, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a ceiling value of $5,593.77. This competitively awarded, firm fixed-price delivery order is non-set-aside and scheduled for completion by September 12, 2025. The award leverages AmerisourceBergen's position as a prime contractor under the DLA Troop Support Medical Indefinite Delivery Contract (SPE2DX), a $999.999 billion...
- The Defense Logistics Agency awarded a delivery order valued at $11,789.94 to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (60 count) on November 7, 2025, with a completion date of December 2, 2025. This firm fixed-price, non-set-aside contract will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Calquence 100 mg tablets (60-count) with a ceiling value of $11,187.56. This firm fixed-price delivery order, with an ultimate completion date of September 5, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The contract involves no set-aside designation, indicating it was competitively awarded. Performance will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Calquence 100 mg tablets (60 count) with a ceiling value of $5,593.77. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order is scheduled for completion by...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Calquence 100 mg tablets (60-count units) under a firm fixed-price contract. The delivery order, valued at $5,593.77 with an ultimate completion date of October 21, 2025, represents a non-competitive, non-set-aside award supporting federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order valued at $5,593.77 to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (60-count units) on September 22, 2025, with completion targeted for October 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents performance to be fulfilled at the vendor's Conshohocken, Pennsylvania location. The award is issued as a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $5,593.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Calquence 100 mg tablets (60-count units). This non-set-aside contract is scheduled for completion by September 16, 2025, with performance at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a ceiling value of $5,593.77. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and was competitively awarded without set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX4DUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a ceiling value of $5,593.77. This is a firm fixed-price delivery order with an ultimate completion date of November 24, 2025. The award represents a non-competitive, non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. Performance will be delivered from the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. The company holds substantial contract authority to supply a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. This delivery order for Calquence, an oncology medication, exemplifies the routine pharmaceutical procurement conducted through the DLA's prime vendor agreements, which provide flexible access to brand-name and generic drugs, specialty medications, and medical supplies to support Department of Defense healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 10/31/25 |